94453 ⎘
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems; Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2 Oxygen atoms
INHIBITORS OF MARK4 AND METHODS OF USE
#2KIT INHIBITORS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
#3CYCLOALKYL CARBOXYLIC ACID DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF
#4HSD17B13 INHIBITORS AND USES THEREOF
#5RXFP1 AGONISTS
#6PARG INHIBITORY COMPOUNDS
#7COMPOUNDS FOR INHIBITING INOSITOL HEXAKISPHOSPHATE KINASE (IP6K) AND METHODS OF USE THEREOF
#8COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES
#9METHOD FOR CATALYTICALLY ACTIVATING CARBON DIOXIDE AS CARBONYLATION REAGENT WITH INORGANIC SULFUR
#10SUBSTITUTED BENZODIAZOLES AND USE THEREOF IN THERAPY
#11T-TYPE CALCIUM CHANNEL BLOCKER
#12BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
#13APPLICATIONS OF BIASED LIGANDS OF THE SEROTONIN 5-HT7 RECEPTOR FOR THE TREATMENT OF PAIN, MULTIPLE SCLEROSIS AND THE CONTROL OF THERMOREGULATION
#14N-(BENZOYL)-PHENYLALANINE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF
#15THERAPEUTIC COMPOUNDS AND USES THEREOF
#16DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENT
#17ARYL ETHER COMPOUNDS AS TEAD MODULATORS
#18HSD17B13 INHIBITORS AND USES THEREOF
#19NOVEL COMPOUNDS
#20PROTEASOME ENHANCERS AND USES THEREOF
#21NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF
#22NOVEL SOLUBLE EPOXIDE HYDROLASE INHIBITORS AND METHOD OF USE THEREOF
#23IL4I1 INHIBITORS AND METHODS OF USE
#24SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF
#25BENZIMIDAZOLONE-BASED CINNAMAMIDE DERIVATIVE AS TRPV1 ANTAGONIST AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF PAIN CONTAINING SAME AS ACTIVE INGREDIENT
#26HETEROCYCLIC COMPOUND, APPLICATION THEREOF, AND COMPOSITION CONTAINING SAME
#27Biarylmethyl heterocycles
#28Ion channel antagonists/blockers and uses thereof
#29SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
#30CRYSTAL FORM OF BENZIMIDAZOLE-2-ONE COMPOUND, SOLVATE THEREOF, CRYSTAL FORM OF SOLVATE THEREOF, AND PREPARATION METHOD THEREOF
#31Dihydrobenzimidazolones for medical treatment
#32COMPOUND FOR TREATING AUTOIMMUNE SKIN DISEASES CAUSED BY INFLAMMATION, AND USE THEREOF
#33SMALL MOLECULE GRB2 STABILIZERS FOR RAS MAP KINASE INHIBITION
#34Thiol compound, method for synthesizing same, and uses for said thiol compound
#35Preparation of benzimidazolone derivatives as novel diacylglyceride O-acyltransferase 2 inhibitors
#36DIRECT AMPK ACTIVATORS
#37COLORING COMPOSITION, FILM, COLOR FILTER, AND SOLID-STATE IMAGING ELEMENT
#38NOVEL BENZIMIDAZOLONE COMPOUND AND PHARMACEUTICAL USE THEREOF
#39PARG inhibitory compounds
#40MODULATORS OF ROR-GAMMA
#41Method for Producing Alpha-Azidoaniline Derivative or Alpha,AlphaPrime-Diazide Derivative
#42One pot synthesis of 4-(1,2-dihydro-2-oxobenzo[d]imidazol-3-yl)butanoic acid, a key intermediate of zilpaterol
#43Compositions for the treatment of pulmonary fibrosis
#44Method for monitoring fluorescent polymer antiscalants in industrial water systems
#45Substituted benzodiazoles and use thereof in therapy
#46Thiol compounds, synthesis method therefor, and utilization of said thiol compounds
#47Sulfonylureas and related compounds and use of same
#48Compounds, process for obtaining the compounds, pharmaceutical composition, use of the compounds and method for treating psychiatric disorders and/or sleep disorders
#49Therapeutic compounds as inhibitors of the orexin-1 receptor
#50Dihydrobenzimidazolones for medical treatment
#51PARG inhibitory compounds
#52Bicyclic imidazole derivatives useful for the treatment of renal diseases, cardiovascular diseases and fibrotic diseases
#53Substituted benzoimidazoles as modulators of ROR-γ
#54Small molecule FIEL1 inhibitor in inflammatory and fibrotic lung injury
#55Methods for forming aryl carbon-nitrogen bond using light
#56Compositions for the treatment of pulmonary fibrosis
#57Compounds, process for obtaining the compounds, pharmaceutical composition, use of the compounds and method for treating psychiatric disorders and/or sleep disorders
#58Cyclic compound acting as PDE4 inhibitor
#59Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
#60Biarylmethyl heterocycles
#619-MEMBERED FUSED RING DERIVATIVE
#62Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators
#63Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
#64Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#65Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes
#66Substituted indoles as modulators of ROR-gamma
#67Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#68PARG inhibitory compounds
#69METHOD FOR PREPARING TRITYL CANDESARTAN
#70Small molecule FIEL1 inhibitor in inflammatory and fibrotic lung injury
#71Cyclic vinylogous amides as bromodomain inhibitors
#729-membered fused ring derivative
#73INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#74Direct AMPK activators
#75Phthalocyanine compound and method of preparing the same, color filter containing phthalocyanine compound, and coloring composition
#76Therapeutic compounds as inhibitors of the orexin-1 receptor
#77Antivirals against molluscum contagiosum virus
#78BICYCLIC HETEROCYCLES CAPABLE OF MODULATING T-CELL RESPONSES, AND METHODS OF USING SAME
#79TRPV1 vanilloid receptor antagonists with a bicyclic portion
#80Methylacryloyl benzimidazolone derivative and anti-tumour use thereof
#81Sulfenamides as flame retardants
#82TRPV1 Vanilloid Receptor Antagonists With A Bicyclic Portion
#83Compositions for the treatment of hypertension and/or fibrosis
#84SUBSTITUTED PHENYLALANINE DERIVATIVES
#85Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#86SUBSTITUTED PHENYLALANINE DERIVATIVES
#87Indoles as respiratory syncytial virus antiviral agents
#88SUBSTITUTED PHENYLALANINE DERIVATIVES
#89SUBSTITUTED PHENYLALANINE DERIVATIVES
#90Active light sensitive or radiation sensitive resin composition, active light sensitive or radiation sensitive film, mask blank provided with active light sensitive or radiation sensitive film, pattern forming method, method for manufacturing electronic device, electronic device and novel compound
#91Cyclic vinylogous amides as bromodomain inhibitors
#92Compound, dispersant and toner
#931,3-diaminocyclopentane carboxamide derivatives
#94BROMODOMAIN INHIBITORS FOR TREATING DISEASE
#95Compounds useful as antibiotic tolerance inhibitors
#96Heterocyclic derivative and pharmaceutical drug
#97Quinazoline-2,4(1 H,3H)-dione derivatives
#98Sulfated Benzimidazolone Derivatives Having Mixed Serotonine Receptor Affinity
#99Amine derivative or salt thereof
#100GPR40 receptor agonist, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
#101Fused ring analogues of anti-fibrotic agents
#102Substituted 2,2′-biphenazines for treating diseases
#103SELECTIVE INHIBITORS OF HISTONE DEACETYLASE ISOFORM 6 AND METHODS THEREOF
#104Activators of human pyruvate kinase
#105NOVEL 4-SUBSTITUTED 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH BENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS
#106Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof
#107BICYCLIC HETEROCYCLES CAPABLE OF MODULATING T-CELL RESPONSES, AND METHODS OF USING SAME
#108Salts
#109Compounds and methods for treating mammalian gastrointestinal microbial infections
#110Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#111HIGHLY SELECTIVE SIGMA RECEPTOR LIGANDS
#112PROCESS FOR THE PREPARATION OF AZILSARTAN MEDOXOMIL OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#113Sulfated Benzimidazolone Derivatives Having Mixed Serotonine Receptor Affinity
#114USE OF A POLYMORPH OF FLIBANSERIN FOR TREATING DISEASE
#115Actinic ray-sensitive or radiation-sensitive resin composition, and, actinic ray-sensitive or radiation-sensitive film and pattern forming method, each using the same
#116Pharmaceutical compositions containing flibanserin
#117Compound as KCNQ potassium channel agonist, preparation method therefor and use thereof
#118Highly selective sigma receptor ligands and radioligands as probes in nociceptive processing and the pathphysiological study of memory deficits and cognitive disorders
#119HETEROCYCLIC COMPOUNDS AS B-RAF INHIBITORS FOR TREATMENT OF CANCER
#120HIV replication inhibitor
#121Heterocyclic derivative and pharmaceutical drug
#122INHIBITORS OF BACTERIAL TYPE III SECRETION SYSTEM
#123Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#124Hydroxamic acid derivatives
#125BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#126Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#127Solid forms of curcumin
#128NMDA receptor antagonists for neuroprotection
#129WNT PATHWAY ANTAGONISTS
#130Fused ring analogues of anti-fibrotic agents
#131Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same
#132BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#1332,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS
#134Methods and compositions related to dopaminergic neuronal cells
#135Positive allosteric modulators of MGLUR2
#136Functionally selective ligands of dopamine Dreceptors
#137ACTIVATORS OF HUMAN PYRUVATE KINASE
#138TRPV1 vanilloid receptor antagonists with a bicyclic portion
#139Cyclourea Compounds as Calcium Channel Blockers
#140NEW SALTS
#141Compounds which have activity at M1 receptor and their uses in medicine
#142Piperidine and piperazine derivatives
#143Compounds which have activity at M1 receptor and their uses in medicine
#144Cyclic benzimidazole derivatives useful as anti-diabetic agents
#145CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#146USE OF A POLYMORPH OF FLIBANSERIN FOR TREATING DISEASE
#147FUSED RING ANALOGUES OF ANTI-FIBROTIC AGENTS
#148Dual-acting benzoimidazole antihypertensive agents
#149Phthalocyanine compound and production method therefor, and coloring composition containing the phthalocyanine compound
#1502,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
#151Small-molecule modulators of Trp-p8 activity
#1522,2′-biphenazine compounds and methods useful for treating disease
#153Anti-cancer compound and pharmaceutical composition containing the same
#154PIPERAZINYL-ALKYL-BENZOIMIDAZOL-2-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS
#155Wnt pathway antagonists
#156Substituted benzimidazolone derivatives, medicaments comprising them and their use
#157NEW SALTS
#158Compounds and methods for treating mammalian gastrointestinal microbial infections
#159Nociceptin analogs
#160Compositions and methods for the treatment of disease associated with TRP-P8 expression
#161Small-molecule modulators of Trp-p8 activity
#162BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
#163BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
#164Substituted phenylpiperazinyl aralkylalcohol derivatives, pharmaceutical compositions containing such derivatives and uses thereof
#165Self-assembled nanostructures
#166Highly selective sigma receptor radioligands
#167Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
#168Hydroxamic acid derivatives
#169PIPERAZINE DERIVATIVES
#170Aryl guanidine FF-ATPase inhibitors and related methods
#171BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
#172Cyclic benzimidazole derivatives useful as anti-diabetic agents
#173Highly selective sigma receptor ligands
#174Processes for the preparation of bendamustine
#175NITROGEN-CONTAINING HETEROCYCLE DERIVATIVES SUBSTITUTED WITH CYCLIC GROUP
#176Bicyclic heteroaryl compounds
#1774-PHENYL-PIPERAZIN-1-YL-ALKYL-BENZOIMIDAZOL-2-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE IN-HIBITORS
#178Sulfated benzimidazolone derivatives having mixed serotonin receptor affinity
#179METHOD FOR PRODUCING COMPOUND HAVING DEUTERATED AROMATIC RING OR HETEROCYCLIC RING
#180Highly selective sigma receptor ligands
#181Therapeutic Molecules and Methods-1
#182DEPROTECTION OF BOC-PROTECTED COMPOUNDS
#183BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#184Compounds with Antiparasitic Activity, Applications thereof to the Treatment of Infectious Diseases Caused by Apicomplexans
#185BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
#1862,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
#187Benzimidazolone chymase inhibitors
#188Piperidine and piperazine derivatives
#189BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS
#190BENZIMIDAZOLE DERIVATIVE
#191BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
#192Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#193Substituted benzimidazolone derivatives, medicaments comprising them and their use
#194Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
#195Process to prepare new substituted 1-benzo[]imidazol-2(3)-ones, new intermediates and their use as BACE 1 inhibitors
#196Cyclic benzimidazole derivatives useful as anti-diabetic agents
#197Certain Chemical Entities, Compositions, and Methods
#198Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions, and Uses Thereof
#199BENZIMIDAZOLE COMPOUNDS
#200Substituted arylalkanoic acid derivatives and use thereof
#201N-(3-AMINO-2-HYDROXY-PROPYL) SUBSTITUTED ALKYLAMIDE COMPOUNDS
#202AMIDE COMPOUND
#203NON-IMIDAZOLE ARYLOXYALKYLAMINES
#204TYROSINE DERIVATIVE
#205Methods and Compositions for Modulating Glycosylation
#206Fused heterocyclic compounds
#207Imidazopyridinyl benzamide mitotic kinesin inhibitors
#208Imidazopyridinyl benzamide mitotic kinesin inhibitors
#209BENZIMIDAZOLONE DERIVATIVES
#210CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#211Organic compound, charge-transporting material, composition for charge-transporting material and organic electroluminescent device
#212COLORING MATTER FOR ANISOTROPIC COLORING MATTER FILM, COMPOSITION COMPRISING SAID COLORING MATTER, ANISOTROPIC COLORING MATTER FILM, AND POLARIZING ELEMENT
#213Prophylactic/Therapeutic Agent for Diabetes
#214NMDA receptor antagonists for neuroprotection
#215Benzimidazolone derivatives as CB2 receptor ligands
#216Cyclourea compounds as calcium channel blockers
#217Nociceptin analogs
#218Dual-acting benzoimidazole antihypertensive agents
#219TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS
#220N-acylsulfonamide apoptosis promoters
#221MIF Inhibitors
#222Compositions and Methods for Treating Cancer
#223NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#2243-amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof
#225INHIBITORS OF HSP90
#226Substituted arylalkanoic acid derivatives and use thereof
#227Amide derivative or salt thereof
#228Nitrogen-containing heterocycle derivatives substituted with cyclic group
#229USE OF A POLYMORPH OF FLIBANSERIN FOR TREATING DISEASE
#230MONOAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS
#2312-[[1-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-oxopropyl]azo]-benzoic acid and a process for its preparation
#232Non-nucleoside reverse transcriptase inhibitors
#233NON-IMIDAZOLE ARYLOXYALKYLAMINES
#234Compounds which have activity at Mreceptor and their uses in medicine
#235Small-molecule modulators of TRP-P8 activity
#236Certain chemical entities, compositions, and methods
#237COMPOUNDS TO TREAT AMYLOIDOSIS AND PREVENT DEATH OF BETA-CELLS IN TYPE 2 DIABETES MELLITUS
#238Phenylazo-acetoacetanilide derivatives with a polymerizable functional group and related compounds as monomers for preparing polymeric pigment dispersants for inkjet inks
#239BIS-SULFONAMIDE HYDROXYETHYLAMINO RETROVIRAL PROTEASE INHIBITORS
#240Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
#241Benzimidazole TRPV1 inhibitors
#242Process for the Production of Candesartan
#243Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
#244Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators
#245Materials and methods to potentiate cancer treatment
#246Benzene, Pyridine, and Pyridazine Derivatives
#247Benzoureas Having Anti-Diabetic Activity
#248BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS
#249Compounds which have activity at M1 receptor and their uses in medicine
#250BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS
#251Biaryl Derivatives
#252Substituted bis aryl and heteroaryl compounds as selective 5HTantagonists
#253Benzimidazole derivatives, their production and use
#254Novel Compounds
#255Phenethanolamine derivatives for treatment of respiratory diseases
#256Small-molecule modulators of TRP-p8 activity
#257Substituted arylalkanoic acid derivatives and use thereof
#258Pharmaceutical compositions containing flibanserin
#259Novel heterocyclic compound
#260Therapeutic amide derivatives
#261Compounds for the treatment of inflammatory disorders and microbial diseases
#262Imidazoyl-benzamide anti-cancer agents
#2633-amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof
#264Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
#265Heat-shock protein binders
#266Substituted propylamine derivatives and methods of their use
#267Phenylaminopropanol derivatives and methods of their use
#268Monocyclic and bicyclic compounds and methods of use
#269Tricyclic steroid hormone nuclear receptor modulators
#270Stable polymorph of flibanserin
#271Stable polymorph of flibanserin
#272Benzimidazolone and dihydroindolone derivatives and uses thereof
#273Substituted aryloxymethyl bicyclicmethyl acetamide compounds
#274Benzimidazolidinone derivatives as muscarinic agents
#275Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
#276N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
#277Non-imidazole aryloxyalkylamines
#278Hydroxysteroid dehydrogenase inhibitors
#279Bicyclic anilide spirohydantoin CGRP receptor antagonists
#280Preventives/remedies for urinary disturbance
#281Histone deacetylase inhibitors
#282Benzimidazolidinone derivatives as muscarinic agents
#283Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
#284Benzimidazolidinone derivatives as muscarinic agents
#285N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds
#286Sulfonamide inhibitors of aspartyl protease
#287Imidazole and benzimidazole derivatives useful as histamine Hantagonists
#288Benzo[]imidazol analogs as vanilloid receptor ligands and their use in treatments
#289Therapeutic molecules and methods-1
#290Acetoacetylation of alcohols, thiols and amines in a microreactor
#291Gonadotropin releasing hormone receptor antagonists
#292Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif)
#293Imidazopyridinyl-benzamide anti-cancer agents
#294Compositions and methods comprising proteinase activated receptor antagonists
#295Preventives/remedies for urinary disturbance
#296Tricyclic steroid hormone nuclear receptor modulators
#297Benzimidazolone compound
#298Serotonergic 5HTreceptor compounds for treating ocular and CNS disorders
#299Benzimidazolidinone derivatives as muscarinic agents
#3002-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as βagonists